Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial

12/15-Lipoxygenase Orchestrates the Clearance of Apoptotic Cells and Maintains Immunologic Tolerance

(2012) Stefan Uderhardt et al.   IMMUNITY

Rapid induction of inflammatory lipid mediators by the inflammasome in vivo

(2012) Jakob von Moltke et al.   NATURE

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Nonresolving Inflammation

(2010) Carl Nathan et al.   CELL

Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways

(2010) T. Morris et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Endogenous LXA4 Circuits Are Determinants of Pathological Angiogenesis in Response to Chronic Injury

(2009) Alexander J. Leedom et al.   AMERICAN JOURNAL OF PATHOLOGY

Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress

(2009) M Spite et al.   BRITISH JOURNAL OF PHARMACOLOGY

Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins

(2009) Ana González-Périz et al.   FASEB JOURNAL

Acute Changes in Dietary  -3 and  -6 Polyunsaturated Fatty Acids Have a Pronounced Impact on Survival following Ischemic Renal Injury and Formation of Renoprotective Docosahexaenoic Acid-Derived Protectin D1

(2009) I. R. Hassan et al.   JOURNAL OF IMMUNOLOGY

Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis

(2009) Amer Awad et al.   JOURNAL OF NEUROIMMUNOLOGY

Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion

(2009) Chengcan Yao et al.   NATURE MEDICINE